Integrated BioPharma Balance Sheet
Integrated BioPharma's total assets for Q2 2026 were $23.55M, a decrease of -7.80% from the previous quarter. INBP total liabilities were $3.78M for the fiscal quarter, a -25.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.